The Effects of Product Liability Exemption in the Presence of the FDA
---- Acknowledgements -----
Prepared for the NBER conference “Regulation and Litigation”, Sep 11-12, 2009, Arizona. We are indebted to Yang Lu for excellent research assistance, the conference participants at the NBER Law and Economics conference, and two anonymous referees for comments and suggestions. Sun gratefully acknowledges funding from the Medical Scientist Training Program at the University of Chicago (NIGMS Grant number 5 T32 GM07281). The views expressed herein are those of the author(s) and do not necessarily reflect the views of the National Bureau of Economic Research.